In the last trading session, 3.41 million CytomX Therapeutics Inc (NASDAQ:CTMX) shares changed hands as the company’s beta touched 2.12. With the company’s per share price at $2.64 changed hands at $0.24 or 10.00% during last session, the market valuation stood at $415.92M. CTMX’s last price was a discount, traded about -6.82% off its 52-week high of $2.82. The share price had its 52-week low at $0.40, which suggests the last value was 84.85% up since then.
Analysts gave the CytomX Therapeutics Inc (CTMX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.50. If we narrow down to specifics, the data shows that 0 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended CTMX as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
CytomX Therapeutics Inc (NASDAQ:CTMX) trade information
Instantly CTMX was in green as seen at the end of in last trading. With action -0.38%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 156.31%, with the 5-day performance at -0.38% in the red. However, in the 30-day time frame, CytomX Therapeutics Inc (NASDAQ:CTMX) is 174.86% up.
The consensus price target for the stock as assigned by Wall Street analysts is 5.84, meaning bulls need an upside of 54.79% from its current market value. According to analyst projections, CTMX’s forecast low is 3.25 with 8 as the target high. To hit the forecast high, the stock’s price needs a -203.03% plunge from its current level, while the stock would need to soar -23.11% for it to hit the projected low.
The 2025 estimates are for CytomX Therapeutics Inc earnings to decrease by -124.50%.
CTMX Dividends
CytomX Therapeutics Inc is expected to release its next quarterly earnings report in July.
JANUS HENDERSON GROUP PLC holds the second largest percentage of outstanding shares, with 7.4245% or 6.3 million shares worth $7.72 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 2.46 shares estimated at $6.48 million under it, the former controlled 3.05% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 1.22% of the shares, roughly 981.49 shares worth around $2.59 million.
